Market Cap : 10.52 B | Enterprise Value : 10.34 B | PE Ratio : | PB Ratio : 51.00 |
---|
NAS:BBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BridgeBio Pharma's Total Inventories for the three months ended in Sep. 2020 was $0.00 Mil. BridgeBio Pharma's Cost of Goods Sold for the three months ended in Sep. 2020 was $0.00 Mil.
BridgeBio Pharma's Days Inventory stayed the same from Sep. 2019 (0.00) to Sep. 2020 (0.00).
Total Inventories can be measured by Days Sales of Inventory (DSI).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BridgeBio Pharma's Inventory-to-Revenue for the three months ended in Sep. 2020 was 0.00.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where BridgeBio Pharma's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BridgeBio Pharma's Days Inventory for the fiscal year that ended in Dec. 2019 is calculated as
Days Inventory (A: Dec. 2019 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2018 ) | + | Total Inventories (A: Dec. 2019 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2019 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 2.5 | * | 365 |
= | 0 | / | 2.5 | * | 365 | ||||
= | 0.00 |
BridgeBio Pharma's Days Inventory for the quarter that ended in Sep. 2020 is calculated as:
Days Inventory (Q: Sep. 2020 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Jun. 2020 ) | + | Total Inventories (Q: Sep. 2020 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2020 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 / 4 |
= | 0 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
An increase of Days Inventory may indicate the company's sales slowed.
1. Total Inventories can be measured by Days Sales of Inventory (DSI).
BridgeBio Pharma's Days Sales of Inventory for the three months ended in Sep. 2020 is calculated as
Days Sales of Inventory (DSI) | = | Total Inventories | / | Revenue | * | Days in Period |
= | 0 | / | 8.127 | * | 365 / 4 | |
= |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
BridgeBio Pharma's Inventory Turnover for the three months ended in Sep. 2020 is calculated as
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BridgeBio Pharma's Inventory to Revenue for the three months ended in Sep. 2020 is calculated as
Inventory-to-Revenue | = | Total Inventories | / | Revenue |
= | 0 | / | 8.127 | |
= | 0.00 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
No Headline